Pure Bioscience 

$0.070000
5
+$0.00+0% Monday 19:53

Statistics

Day High
0.07
Day Low
0.07
52W High
0.14
52W Low
0.04
Volume
800
Avg. Volume
-
Mkt Cap
7.83M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

16MarExpected
Q3 2022
Q1 2024
Q3 2024
Q4 2024
Q1 2025
Q3 2025
Q4 2025
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.01

Financials

-108.95%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.4MRevenue
-4.8MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PURE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

PURE Bioscience, Inc. specializes in the creation and market introduction of advanced antimicrobial solutions. These products are designed to tackle critical health and environmental issues related to pathogen and hygiene management, serving both domestic and international markets. A cornerstone of their technology is silver dihydrogen citrate (SDC), a non-toxic antimicrobial compound they produce and supply, renowned for its long-lasting protective qualities and its adaptability for co-formulation with other substances. Their product line, built upon SDC, encompasses various sanitizing and disinfecting agents: PURE Hard Surface: A dual-purpose sanitizer and disinfectant for food preparation areas. PURE Control: Formulated as a processing aid for fresh produce and raw poultry. PURE Multi-Purpose and Floor Cleaner Concentrate: Designed for cleaning diverse resilient surfaces like floors, glass, and even food-contact areas. PURE Multi-Purpose Hi-Foam Cleaner Concentrate: Ideal for robust cleaning of stainless steel, resilient floors, walls, and painted surfaces. Additionally, their portfolio features Axen30, a specialized hard surface disinfectant; Axenohl, an antimicrobial formulation intended as a raw material for consumer and commercial sanitizing product manufacturers; and SILVÉRION, a broad-spectrum antimicrobial effective against bacteria, viruses, yeasts, and molds. Established in 1992, PURE Bioscience, Inc. maintains its corporate headquarters in Rancho Cucamonga, California.
Show more...
CEO
Mr. Robert F. Bartlett
Employees
11
Country
United States
ISIN
US74621T2096

Listings

0 Comments

Share your thoughts

FAQ

What is Pure Bioscience stock price today?
The current price of PURE is $0.07 USD — it has increased by +0% in the past 24 hours. Watch Pure Bioscience stock price performance more closely on the chart.
What is Pure Bioscience stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pure Bioscience stocks are traded under the ticker PURE.
Is Pure Bioscience stock price growing?
PURE stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Pure Bioscience has showed a -15.66% decrease.
What is Pure Bioscience market cap?
Today Pure Bioscience has the market capitalization of 7.83M
What were Pure Bioscience earnings last quarter?
PURE earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pure Bioscience revenue for the last year?
Pure Bioscience revenue for the last year amounts to 4.4M USD.
What is Pure Bioscience net income for the last year?
PURE net income for the last year is -4.8M USD.
How many employees does Pure Bioscience have?
As of June 16, 2026, the company has 11 employees.
In which sector is Pure Bioscience located?
Pure Bioscience operates in the Essentials sector.
When did Pure Bioscience complete a stock split?
The last stock split for Pure Bioscience was on August 15, 2012 with a ratio of 1:8.
Where is Pure Bioscience headquartered?
Pure Bioscience is headquartered in El Cajon, United States.